Why is it not recommended to take Roaccutane (Isotretinoin) at night? Choose the medication time scientifically
Roaccutane (Isotretinoin) is an oral vitamin A acid drug that is mainly metabolized by the liver and forms active metabolites in the blood. Its absorption is closely related to food, especially high-fat diet, which can significantly improve drug bioavailability. If taken in the evening on an empty stomach or with a low-fat dinner, the drug may not be absorbed enough, thus reducing its efficacy.
Taking medication at night may increase the incidence of gastrointestinal discomfort, such as nausea, stomach pain, acid reflux and other symptoms. Because isotretinoinA acid significantly stimulates the gastric mucosa, and gastrointestinal motility slows down at night, which can easily cause indigestion or sleep disruption. In addition, taking medication at night may also affect the nighttime metabolic rhythm of the liver, causing some patients to experience mild liver function fluctuations or elevated blood lipids.

It is clinically recommended to take Roaccutane with breakfast or lunch and with a high-fat diet to improve drug absorption and blood concentration stability. Taking medication at a fixed time can help maintain blood drug concentration, reduce fluctuations, and reduce the incidence of gastrointestinal discomfort. For patients on long-term treatment, taking it at the same time every day can also help develop a routine and improve medication compliance.
In addition to choosing the appropriate medication time, patients should avoid taking it with an empty stomach or low-fat meal, and regularly monitor liver function, blood lipids, and blood routine during medication. For people who work at night or have irregular schedules, they can make reasonable adjustments according to breakfast or lunch time, but they still need to ensure that the medicine is taken with a high-fat meal. By scientifically arranging the medication time, the efficacy of Roaccutane can be improved, the risk of adverse reactions can be reduced, and the safety and tolerability of long-term treatment can be ensured.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)